Arcus Biosciences, Inc.
Clinical trials sponsored by Arcus Biosciences, Inc., explained in plain language.
-
New combo therapy shows promise for Tough-to-Treat colon cancer
Disease control CompletedThis study tested combinations of a drug called etrumadenant (AB928) with other treatments in 227 adults whose colorectal cancer had spread. The goal was to see if these combos could shrink tumors or slow cancer growth, and to check for side effects. Participants had to be in fai…
Phase: PHASE1, PHASE2 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Healthy men help scientists track Drug's journey through the body
Knowledge-focused CompletedThis study looked at how healthy adult men process and eliminate a single dose of the drug quemliclustat. Eight participants received a radioactive-labeled version of the drug so researchers could track it in blood, urine, and feces. The goal was to understand how the drug leaves…
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:59 UTC
-
Healthy volunteers help test new drug interactions
Knowledge-focused CompletedThis study looked at how a new drug called casdatifan interacts with two other common drugs (itraconazole and phenytoin) in 14 healthy adults. The goal was to measure drug levels in the blood and check for side effects. Participants were healthy volunteers aged 18-55 who did not …
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:54 UTC